Add like
Add dislike
Add to saved papers

Contemporary Outcomes for Functional Single Ventricle with Total Anomalous Pulmonary Venous Connection.

OBJECTIVE: In 2004, we reported improved early survival for patients with functional single ventricle anatomy and total anomalous pulmonary venous connection (SV/TAPVC). This study sought to discover if outcomes have ameliorated in the contemporary era.

METHODS: This was a single-center review of patients with SV/TAPVC admitted from 1984 to 2021. The cohort was divided into similarly sized groups by date of admission: Era 1- 1984 to 1992, Era 2- 1993 to 2007, and Era 3- 2008 to 2021. Survival was compared and Cox proportional hazards models were used to evaluate the likelihood of mortality.

RESULTS: We included 190 patients with SV/TAPVC. Unbalanced atrioventricular canal defect (70%) was the most common primary diagnosis. The most common type of TAPVC was supracardiac (49%). Approximately one-third (32%) of patients had pulmonary venous obstruction. There were no significant differences in patient characteristics across eras. Early survival after initial palliative operation improved between Eras 1 and 2, then remained stable in Era 3. Overall survival improved from Era 1 to Eras 2 and 3 (p < 0.001), but not between Era 2 and 3. Survival to 10 years by era was 15%, 51%, and 54%. The anatomic features associated with worse survival were HLHS diagnosis (Hazard Ratio [HR] 1.60; 1.04- 2.57) and pulmonary venous obstruction (HR 1.80; 1.24-2.69).

CONCLUSIONS: Overall survival for patients with SV/TAPVC has plateaued since the early 2000s. Even in the most recent era, survival to age 10 remains less than 60%. Risk factors for mortality include the diagnosis of HLHS and pulmonary venous obstruction. Further studies should focus on identification of the pathophysiological factors underlying the increased mortality.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app